Global MRI Guided and Focused Ultrasound Devices Market Size By Type (MRI Guided, Focused Ultrasound), By Application (Uterine Fibroids, Prostate Disease), By Region, And Segment Forecasts, 2023 to 20...

The Global MRI Guided and Focused Ultrasound Devices Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 3.5 billion by 2031, growing at a robust CAGR of 15.4% during the forecast period. The market growth is driven by the increasing adoption of non-invasive treatment options, technological advancements in imaging and therapeutic devices, and rising incidences of neurological disorders, uterine fibroids, and cancers that benefit from targeted ultrasound therapy. MRI-guided focused ultrasound (MRgFUS) combines high-intensity ultrasound energy with magnetic resonance imaging to provide real-time treatment monitoring, offering a precise and minimally invasive alternative to traditional surgical methods.

Drivers:

1. Rising Demand for Non-Invasive Treatment Modalities:

The growing patient preference for non-invasive and low-risk treatment options is significantly driving the adoption of MRgFUS. The ability to treat conditions like essential tremor, Parkinson’s disease, uterine fibroids, and prostate cancer without surgical incisions has expanded the therapeutic scope of these devices.

2. Technological Innovations in Imaging and Ultrasound Therapy:

Recent advancements have enabled the development of highly accurate and efficient MRgFUS systems. Integration with AI, improved imaging resolution, and adaptive focusing techniques are making treatments safer and more effective, thus boosting market growth.

3. Increasing Neurological Disorder Prevalence:

The global rise in neurological disorders such as Alzheimer’s disease and essential tremor has emphasized the need for advanced treatment alternatives. MRgFUS has emerged as a promising solution, especially in the treatment of movement disorders and neuropathic pain.

Restraints:

1. High Equipment and Procedure Costs:

The cost-intensive nature of MRI-guided focused ultrasound systems, along with the need for highly specialized facilities and personnel, restricts widespread adoption, particularly in developing economies.

2. Limited Reimbursement Policies:

In several countries, limited insurance coverage and lack of standard reimbursement for MRgFUS procedures remain significant barriers to market expansion, impacting patient accessibility.

Opportunity:

1. Expanding Clinical Applications:

Beyond its current use in oncology and neurology, ongoing clinical trials are exploring MRgFUS for treating epilepsy, depression, and even blood-brain barrier opening for targeted drug delivery. This expansion presents a substantial opportunity for market growth.

2. Growth Potential in Emerging Markets:

Rising healthcare infrastructure, increasing awareness, and improving regulatory support in Asia-Pacific and Latin America offer significant growth potential for market players looking to expand their footprint.

Market by System Type Insights:

The market is segmented into Transcranial MRgFUS Systems, ExAblate Neuro, and ExAblate Body. Among these, Transcranial MRgFUS Systems accounted for the largest share in 2023 due to their high application in neurological treatments, especially for essential tremor and Parkinson’s disease. The ExAblate Neuro system is gaining traction due to its precise targeting capabilities and real-time monitoring advantages.

Market by End-Use Insights:

By end-use, the Hospitals & Clinics segment dominated the market in 2023, driven by the availability of advanced infrastructure and skilled professionals. The Research & Academic Institutions segment is projected to grow rapidly during the forecast period, fueled by increased R&D initiatives in focused ultrasound therapy and expanding clinical trials.

Market by Regional Insights:

North America led the global market in 2023, accounting for the largest revenue share, supported by advanced healthcare systems, favorable reimbursement frameworks, and strong presence of key industry players. Asia-Pacific is anticipated to witness the highest growth rate due to increasing investment in healthcare technology, rising patient awareness, and growing medical tourism in countries like China, India, and South Korea.

Competitive Scenario:

Key players operating in the Global MRI Guided and Focused Ultrasound Devices Market include:

Insightec Ltd.

Profound Medical Corp.

Philips Healthcare

GE Healthcare

Siemens Healthineers

Theraclion

FUS Instruments

Alpinion Medical Systems

Image Guided Therapy

Kona Medical

These companies are focusing on strategic collaborations, FDA approvals, and technological enhancements to strengthen their position. For instance:

In 2023, Insightec received expanded FDA approval for its MRgFUS system to treat Parkinson’s disease with dyskinesia.

Profound Medical entered a strategic partnership with a leading U.S. hospital network in 2024 to expand the clinical adoption of its TULSA-PRO system.

Scope of Work – Global MRI Guided and Focused Ultrasound Devices Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 3.5 billion

CAGR (2023–2031) 15.4%

Market Segments By System Type, By End-Use, By Region

Growth Drivers Non-invasive treatment demand, technological advancements, neurological disorder prevalence

Opportunities Emerging applications, expansion in Asia-Pacific and Latin America

Key Market Developments:

2023: Insightec's Exablate Neuro received CE mark approval for treating neuropathic pain.

2024: Philips launched a next-gen MRgFUS system integrating AI for adaptive therapy modulation.

2025: Profound Medical announced the initiation of a global clinical trial exploring MRgFUS for prostate cancer in early stages.

FAQs:

1. What is the current market size of the Global MRI Guided and Focused Ultrasound Devices Market?

The market size in 2023 is USD 1.1 billion.

2. What is the major growth driver of the Global MRI Guided and Focused Ultrasound Devices Market?

The major driver is the rising demand for non-invasive treatment solutions and technological innovations in imaging and therapeutic devices.

3. Which is the largest region during the forecast period in the Global MRI Guided and Focused Ultrasound Devices Market?

North America is the largest regional market during the forecast period.

4. Which segment accounted for the largest market share in the Global MRI Guided and Focused Ultrasound Devices Market?

The Transcranial MRgFUS Systems segment held the largest market share in 2023.

5. Who are the key market players in the Global MRI Guided and Focused Ultrasound Devices Market?

Major players include Insightec Ltd., Profound Medical Corp., Philips Healthcare, GE Healthcare, and Siemens Healthineers.